About Kinomica
Kinomica is a company based in Macclesfield (United Kingdom) founded in 2017 by John Gribben, Pedro Cutillas, and David Britton. Kinomica has raised $5.16 million across 2 funding rounds from investors including Alderley Park, BioCity and BGF. The company has 13 employees as of June 30, 2021. Kinomica offers products and services including KScan®. Kinomica operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter Macclesfield, United Kingdom
- Employees 13 as on 30 Jun, 2021
- Founders John Gribben, Pedro Cutillas, David Britton
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Kinomica Limited
- Date of Incorporation 01 Oct, 2016
- Jurisdiction MACCLESFIELD, CHESHIRE, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.16 M (USD)
in 2 rounds
-
Latest Funding Round
$5.16 M (USD), Series A
Dec 14, 2020
-
Investors
Alderley Park
& 4 more
-
Employee Count
13
as on Jun 30, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kinomica
Kinomica offers a comprehensive portfolio of products and services, including KScan®.
Analyzes protein phosphorylation for cancer treatment selection and precision medicine.
People of Kinomica
Unlock access to complete
Unlock access to complete
Funding Insights of Kinomica
Kinomica has successfully raised a total of $5.16M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.16 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Kinomica
Kinomica has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Alderley Park, BioCity and BGF.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early & Growth stage tech & offline focused VC firm funding companies in the UK & Ireland
|
Locked | Locked | Locked | |
|
Early-stage deeptech businesses are supported through venture capital investments.
|
Locked | Locked | Locked | |
|
Life Science focused startup accelerator and incubator
|
Locked | Locked | Locked |
Investor details for Kinomica
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kinomica
Investment portfolio details for Kinomica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kinomica
Detailed financials for Kinomica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kinomica Comparisons
Peer comparison for Kinomica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kinomica
Kinomica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
Detailed competitors of Kinomica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kinomica
Complete news archive for Kinomica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kinomica
Kinomica was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Kinomica is headquartered in Macclesfield, United Kingdom. It is registered at Macclesfield, Cheshire, United Kingdom.
Jane Theaker is the current CEO of Kinomica.
Kinomica is a funded company, having raised a total of $5.16M across 2 funding rounds to date.
As of Jun 30, 2021, the latest employee count at Kinomica is 13.
Kinomica was founded in 2017 and is headquartered in Macclesfield, United Kingdom. A bioinformatics platform is provided by the company within the precision medicine sector. Proprietary bioinformatics and LC-MSMS phospho-proteomics are utilized to examine cellular signaling activities and biochemical network changes. Applications encompass the study of disease mechanisms, identification of drug targets and biomarkers, assessment of drug efficacy, and determination of therapy responders.
Kinomica's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Kinomica offers KScan®.
Kinomica has 5 investors. Key investors include Alderley Park, BioCity, BGF, Longwall Ventures, and Puffin Point.